News
Looking back, it was probably the pop culture moment that signified the downfall of society as we clapped and cheered on ...
23mon MSNOpinion
OPINION - The soaring price of weight loss drugs could derail the NHS's obesity plan - unless they take this action
The September price hike is a warning shot. It shows what happens when private demand surges ahead of public provision. The ...
We all want to live long, healthy lives—but what you put on your plate every day could be quietly working against you. While some foods fuel your body and support longevity, others are linked to ...
New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...
Caleb Luna, assistant professor of feminist studies at the University of California, says having someone like Serena Williams ...
People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...
Hers reports Tennessee leads U.S. states in Google searches for weight loss, with rising interest coinciding with decreasing ...
The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...
Jennifer Kerns, a physician in obesity medicine and a contestant of The Biggest Loser, reveals the inner workings of the show ...
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
In this opinion piece, John Bode, president and CEO of the Corn Refiners Association, argues that blaming consumption of high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results